buchspektrum Internet-Buchhandlung

Neuerscheinungen 2015

Stand: 2020-02-01
Herderstraße 10
10625 Berlin
Tel.: 030 315 714 16
Fax 030 315 714 14

Gerd Kleemann, Vladimir I. Razinkov (Beteiligte)

High Throughput Formulation Development of Biopharmaceuticals

Practical Guide to Methods and Applications
2015. 132 S. 234 mm
ISBN: 1-907568-63-8 (1907568638)
Neue ISBN: 978-1-907568-63-3 (9781907568633)

Preis und Lieferzeit: Bitte klicken

High Throughput Formulation Development of Biopharmaceuticals: Practical Guide to Methods and Applications provides the latest developments and information on the science of stable and safe drug product formulations, presenting a comprehensive review and detailed description of modern methodologies in the field of formulation development, a process starting with candidate and pre-formulation screening in its early development phase and then progressing to the refinement of robust formulations during commercialization in the later phases of development.

The title covers topics such as experiment design, automation of sample preparation and measurements, high-throughput analytics, stress-inducing methods, statistical analysis of large amounts of formulation study data, emerging technologies, and the presentation of several case studies, along with a concluding summary.

Presents applications of high-throughput methodologies to accelerate drug formulation development
Provides the latest technologies in the field
Includes key statistical approaches, such as design of experiment and multivariate data analysis
Written by highly respected formulation development experts
1. High-throughput methodology in biopharmaceutical formulation development

2. Early candidate selection and formulation development

3. Preclinical and clinical formulation studies

4. Late-stage and commercial formulation development

5. Analysis of high-throughput data
Razinkov, Vladimir I.
Vladimir Razinkov is a principal scientist in the Department of Drug Product Development, Amgen Inc., Seattle, WA, USA

Kleemann, Gerd
Gerd R. Kleemann is a scientific director in the Department of Drug Product Development, Amgen Inc., Seattle, WA, USA